Upon initial analysis, there was a down-regulation of T cell populations specifically in the CD4+ T cell compartment in patients with aggressive thyroid cancer defined as: i) AJCC TNM stage 3 or 4, ii) high risk of recurrence by ATA criteria, or iii) demonstrating distant metastases during follow-up. The gene discussed is CD4; the disease is thyroid cancer.